Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coagulation effects of tranexamic acid in supratentorial brain tumor surgery
IRCT20190202042588N3Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tranexamic acid in supratentorial neoplasm, sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
supratentorial neoplasm
Beyond the preview
Go deeper on IRCT20190202042588N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190202042588N3.